8-K: RCM Technologies Reports Strong Q2 2025 Revenue Growth

RCM Technologies announced robust revenue growth and increased adjusted earnings per share for the second quarter and first half of 2025, driven by consistent performance across all segments.

Summary

• For the thirteen weeks ended June 28, 2025, revenue increased by 13.0% to $78.2 million, up from $69.2 million in the comparable prior quarter.
• Gross profit for the quarter rose by 11.4% to $22.3 million, compared to $20.0 million in the prior comparable quarter.
• GAAP net income for the quarter was $3.8 million, or $0.50 per diluted share, a slight increase from $3.8 million, or $0.47 per diluted share, in the prior comparable quarter.
• Adjusted EBITDA (non-GAAP) for the quarter was $8.1 million, an increase from $7.2 million in the prior comparable quarter.
• Adjusted net income per diluted share (non-GAAP) for the quarter increased by 21.1% to $0.69, up from $0.57 in the prior comparable quarter.
• For the twenty-six weeks ended June 28, 2025, revenue increased by 15.3% to $162.6 million, up from $141.1 million in the comparable prior-year period.
• Gross profit for the twenty-six weeks increased by 9.6% to $44.3 million, compared to $40.4 million in the prior comparable period.
• GAAP net income for the twenty-six weeks was $8.0 million, or $1.04 per diluted share, an increase from $7.7 million, or $0.95 per diluted share, in the prior comparable period.
• Adjusted EBITDA (non-GAAP) for the twenty-six weeks was $15.9 million, an increase from $14.0 million in the prior comparable period.
• Adjusted net income per diluted share (non-GAAP) for the twenty-six weeks increased by 18.9% to $1.32, up from $1.11 in the prior comparable period.
• Net cash used in operating activities for the thirteen weeks ended June 28, 2025, was $7.9 million, a decrease from $5.7 million provided in the comparable prior quarter.
• Net cash provided by operating activities for the twenty-six weeks ended June 28, 2025, decreased to $8.8 million from $12.2 million in the comparable prior-year period.

Sentiment

Score: 7

Explanation: The company reported strong revenue and adjusted earnings growth across all segments, indicating solid operational performance. However, the significant net cash outflow from operating activities in the second quarter and a decrease in operating cash flow for the first half temper the overall positive sentiment, warranting close monitoring of cash generation.

Positives

• Revenue for the second quarter increased by 13.0% to $78.2 million.
• Revenue for the first half of 2025 increased by 15.3% to $162.6 million.
• Gross profit for the second quarter increased by 11.4% to $22.3 million.
• Gross profit for the first half of 2025 increased by 9.6% to $44.3 million.
• GAAP diluted net earnings per share for the second quarter increased to $0.50 from $0.47.
• GAAP diluted net earnings per share for the first half of 2025 increased to $1.04 from $0.95.
• Adjusted EBITDA (non-GAAP) for the second quarter increased to $8.1 million from $7.2 million.
• Adjusted EBITDA (non-GAAP) for the first half of 2025 increased to $15.9 million from $14.0 million.
• Adjusted net income per diluted share (non-GAAP) for the second quarter increased by 21.1% to $0.69.
• Adjusted net income per diluted share (non-GAAP) for the first half of 2025 increased by 18.9% to $1.32.
• Consistent growth was observed across all three segments (Specialty Health Care, Engineering, Life Sciences, Data and Solutions).
• Cash and cash equivalents increased to $5.472 million at June 28, 2025, from $4.729 million at December 28, 2024.
• Borrowings under the line of credit decreased to $34.015 million at June 28, 2025, from $34.967 million at December 28, 2024.

Negatives

• Net cash used in operating activities for the thirteen weeks ended June 28, 2025, was $7.878 million, a significant decrease from $5.725 million provided in the comparable prior quarter.
• Net cash provided by operating activities for the twenty-six weeks ended June 28, 2025, decreased to $8.782 million from $12.151 million in the comparable prior-year period.

Risks

• Actual results, performance, or achievements may differ materially from forward-looking statements due to various risks, uncertainties, and other factors.
• Risks include those related to demand for the Company's services, future revenues and other financial results (such as cash flows), pipeline, potential project wins, and expectations for investment and growth in the business.
• Statements are based on current expectations that involve several known and unknown risks, uncertainties, and other factors.
• New risks, uncertainties, and other factors may emerge over time that could cause actual results to differ from forward-looking statements.
• Investors are directed to consider risks, uncertainties, and other factors described in documents filed with the SEC, including the most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q.

Future Outlook

Management anticipates a strong second half of the year, with momentum continuing to build within the Engineering segment, expected to unlock the next leg of growth for the business. Forward-looking statements also include expectations regarding demand for services, future revenues, cash flows, pipeline, potential project wins, and investment and growth in the business.

Management Comments

• Bradley Vizi, Executive Chairman: "The second quarter exhibited consistent growth across all three segments demonstrating the resilience of the model as we build towards an expected strong second half of the year."
• Kevin Miller, Chief Financial Officer: "Momentum within Engineering continues to build as we unlock the next leg of growth in the business."

Industry Context

RCM Technologies operates in diverse and critical sectors including Specialty Health Care, Engineering, and Life Sciences, Data & Solutions. The reported consistent growth across all segments suggests robust demand for specialized business and technology solutions, indicating a healthy market for professional services in these industries. The building momentum in Engineering, specifically, points to strong underlying trends in critical infrastructure and industrial modernization.

Stakeholder Impact

• Shareholders are positively impacted by the increase in GAAP and adjusted diluted earnings per share, reflecting improved profitability.
• Employees in the Engineering segment may see increased opportunities due to building momentum and growth initiatives.
• Customers benefit from the company's continued investment and growth in its service offerings, particularly in critical infrastructure and modernization.

Next Steps

• Host a conference call on Thursday, August 7, 2025, at 11:30 a.m. Eastern Time, to discuss these results.

Key Dates

Recommendation

RCM Technologies demonstrated strong top-line growth and improved profitability on an adjusted basis across all segments for both the quarter and year-to-date periods. The management's outlook for a strong second half of the year and building momentum in Engineering suggest continued positive performance. While Q2 operating cash flow was negative, the overall financial health and growth trajectory, particularly in adjusted metrics, warrant a positive outlook for investors, suggesting a 'buy' recommendation with a focus on future cash flow generation.

Keywords

RCM Technologies, RCMT, Financial Results, Q2 2025, Earnings, Revenue, Adjusted EBITDA, EPS, Specialty Health Care, Engineering, Information Technology, Life Sciences, Data Solutions, Consulting Services, SEC Filing